Le Lézard
Classified in: Health
Subjects: CHI, SVY

National Report: Iowa Ranks 24th in Protecting Kids from Tobacco


WASHINGTON, Dec. 13, 2017 /PRNewswire-USNewswire/ -- Iowa ranks 24th nationwide in funding programs that prevent kids from smoking and help smokers quit, according to a report released today by leading public health organizations. Iowa is spending $4.1 million this year on tobacco prevention and cessation programs, which is just 13.5 percent of the $30.1 million recommended by the Centers for Disease Control and Prevention (CDC).

Campaign for Tobacco-Free Kids logo. (PRNewsFoto/Campaign for Tobacco-Free Kids)

The report challenges states to do more to fight tobacco use ? the nation's leading cause of preventable death ? and make the next generation tobacco-free. In Iowa, 18.1 percent of high school students smoke, and 1,300 kids become regular smokers each year. Tobacco use claims 5,100 Iowa lives and costs the state $1.3 billion in health care bills annually.

Other key findings in the report include:

The report ? "Broken Promises to Our Children: A State-by-State Look at the 1998 Tobacco Settlement 19 Years Later" ? was released by the Campaign for Tobacco-Free Kids, American Cancer Society Cancer Action Network, American Heart Association, American Lung Association, the Robert Wood Johnson Foundation, Americans for Nonsmokers' Rights and Truth Initiative.

The report spotlights the need for stronger tobacco prevention efforts in Iowa. In addition to increasing funding for tobacco prevention (which was slashed this year by over 20 percent), health advocates are urging Iowa leaders to increase the tobacco sale age to 21.

"By failing to adequately fund tobacco prevention and cessation programs, Iowa is putting kids' health at risk and costing taxpayers more in tobacco-related health care costs," said Matthew L. Myers, President of the Campaign for Tobacco-Free Kids. "We can win the fight against tobacco and make the next generation tobacco-free, but Iowa needs to do its part to help us achieve these goals. Raising the state's tobacco age to 21 would be an excellent step."

The U.S. has reduced smoking to record lows ? 15.1 percent among adults and 8 percent among high school students. But tobacco use still kills more than 480,000 Americans and costs the nation about $170 billion in health care bills each year.

Today's report also highlights large disparities in who smokes and who suffers from tobacco-related diseases in the United States. Smoking rates are especially high in a swath of 12 states in the Midwest and South, an area called "Tobacco Nation" in a recent Truth Initiative report. Nationwide, smoking rates are highest among people who live below the poverty level and have less education, American Indians/Alaska Natives, LGBT Americans, those who are uninsured or on Medicaid, and those with mental illness. These differences are in large part due to the tobacco industry's targeting of vulnerable populations through advertising, price discounting and other marketing strategies.

By funding tobacco prevention and cessation programs at the CDC's recommended levels, states can reduce tobacco use among all Americans. But most states are falling far short:

The report and state-specific information can be found at tfk.org/statereport.

 

SOURCE Campaign for Tobacco-Free Kids


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: